Literature DB >> 19169662

A simple two-step protocol for the purification of human pancreatic beta cells.

M Banerjee1, T Otonkoski.   

Abstract

AIMS/HYPOTHESIS: Isolated pure human beta cells would be helpful for a number of research purposes. However, lack of beta cell-specific surface antigens has been a major problem. We aimed to develop a simple method for human beta cell isolation based on the initial elimination of ductal cells by their expression of carbohydrate antigen 19-9 (CA19-9), followed by positive selection of beta cells by their expression of polysialic acid-neural cell adhesion molecule (PSA-NCAM).
METHODS: Cell type-specific expression of CA19-9, NCAM and PSA-NCAM was studied in sections of adult human pancreas and in cultured primary endocrine and exocrine cells. Dispersed human islet cells were purified in two steps, after 4 days of suspension culture, by binding to magnetic microbeads coupled to antibodies against CA19-9 and PSA-NCAM.
RESULTS: NCAM expression was detected in ducts and islets in the human pancreas. In contrast, PSA-NCAM immunoreactivity was detected only in islets. PSA-NCAM staining in dispersed cells revealed that the marker is expressed in all endocrine cell types, but not in duct cells. Purification of dispersed islet cells using PSA-NCAM microbeads alone did not completely eliminate contaminating duct cells. However, elimination of the duct cells by CA19-9 microbeads followed by positive sorting of the PSA-NCAM-positive cells in five consecutive islet preparations resulted in 90 to 98% pure endocrine cells, of which 89 to 97% were beta cells. CONCLUSIONS/
INTERPRETATION: We describe a simple and reproducible method for purification of viable human pancreatic beta cells devoid of exocrine acini and ducts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169662     DOI: 10.1007/s00125-009-1259-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe.

Authors:  B Lukowiak; B Vandewalle; R Riachy; J Kerr-Conte; V Gmyr; S Belaich; J Lefebvre; F Pattou
Journal:  J Histochem Cytochem       Date:  2001-04       Impact factor: 2.479

2.  Sialylated form of the neural cell adhesion molecule (NCAM): a new tool for the identification and sorting of beta-cell subpopulations with different functional activity.

Authors:  C Bernard-Kargar; N Kassis; M F Berthault; W Pralong; A Ktorza
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

3.  A new in vitro model for the study of pancreatic A and B cells.

Authors:  D G Pipeleers; P A in't Veld; M Van de Winkel; E Maes; F C Schuit; W Gepts
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

4.  In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells.

Authors:  R Gao; J Ustinov; O Korsgren; T Otonkoski
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

5.  Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome.

Authors:  Cale N Street; Jonathan R T Lakey; A M James Shapiro; Sharleen Imes; Ray V Rajotte; Edmond A Ryan; James G Lyon; Tatsuya Kin; Jose Avila; Toshiaki Tsujimura; Gregory S Korbutt
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

7.  Differentiation of affinity-purified human pancreatic duct cells to beta-cells.

Authors:  Shigeru Yatoh; Rikke Dodge; Tomoyuki Akashi; Abdulkadir Omer; Arun Sharma; Gordon C Weir; Susan Bonner-Weir
Journal:  Diabetes       Date:  2007-05-01       Impact factor: 9.461

8.  Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9.

Authors:  Valéry Gmyr; Sandrine Belaich; Ghaffar Muharram; Bruno Lukowiak; Brigitte Vandewalle; François Pattou; Julie Kerr-Conte
Journal:  Biochem Biophys Res Commun       Date:  2004-07-16       Impact factor: 3.575

Review 9.  The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions.

Authors:  U Rutishauser; A Acheson; A K Hall; D M Mann; J Sunshine
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

10.  Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation.

Authors:  V Cirulli; D Baetens; U Rutishauser; P A Halban; L Orci; D G Rouiller
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

View more
  11 in total

1.  Getting beta all the time: discovery of reliable markers of beta cell mass.

Authors:  J C Hutton; H W Davidson
Journal:  Diabetologia       Date:  2010-04-22       Impact factor: 10.122

2.  Sensitivity profile of the human EndoC-βH1 beta cell line to proinflammatory cytokines.

Authors:  Ewa Gurgul-Convey; Ilir Mehmeti; Thomas Plötz; Anne Jörns; Sigurd Lenzen
Journal:  Diabetologia       Date:  2016-07-27       Impact factor: 10.122

3.  An optimized protocol for purification of functional islets of Langerhans.

Authors:  Youakim Saliba; Jules-Joel Bakhos; Tarek Itani; Nassim Farès
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

4.  A protocol for islet isolation from mouse pancreas.

Authors:  Dong-Sheng Li; Ya-Hong Yuan; Han-Jun Tu; Qing-Le Liang; Long-Jun Dai
Journal:  Nat Protoc       Date:  2009-10-22       Impact factor: 13.491

5.  Purified human pancreatic duct cell culture conditions defined by serum-free high-content growth factor screening.

Authors:  Corinne A Hoesli; James D Johnson; James M Piret
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

6.  Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets.

Authors:  Revital Sharivkin; Michael D Walker; Yoav Soen
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Epithelial to mesenchymal transition in human endocrine islet cells.

Authors:  José Luis Moreno-Amador; Noèlia Téllez; Sandra Marin; Caterina Aloy-Reverté; Carlos Semino; Montserrat Nacher; Eduard Montanya
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

8.  Navigating the Depths and Avoiding the Shallows of Pancreatic Islet Cell Transcriptomes.

Authors:  Alex M Mawla; Mark O Huising
Journal:  Diabetes       Date:  2019-07       Impact factor: 9.461

9.  Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes.

Authors:  John A Olsen; Lauren A Kenna; Michael G Spelios; Martin J Hessner; Eitan M Akirav
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

10.  Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus.

Authors:  Joo-Yeon Hwang; Hyo Jung Lee; Min Jin Go; Han Byul Jang; Nak-Hyun Choi; Jae Bum Bae; Juan E Castillo-Fernandez; Jordana T Bell; Tim D Spector; Hye-Ja Lee; Bong-Jo Kim
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.